News

From our CEO

25 October 2023

Hard to believe, but we are just a few weeks away from the opening of MSA’s Progress in MS Research Conference to be held in Perth from November 29 to December 1.

This year, the conference is going to be extra special for a number of reasons. First, we have a really big, globally significant announcement to make in partnership with our very good colleagues at MS Western Australia. But you’ll have to wait for the conference to hear more about that.

Second, this year we are seeing our conference expand, running for three days rather than two. This follows feedback from past conferences that the agenda is just too packed for two days, a reflection on the breadth and depth of MS research underway in Australia.

Third, we are embracing the consumer voice, encouraging more people with MS to participate while showcasing some of the excellent research work underway that embraces the lived experience in research, from concept to conclusion.

And fourth, we have a really stellar range of speakers from across the world attending, speakers you won’t want to miss.

As Australia’s pre-eminent MS research conference, we have a well-earned reputation on the international stage, providing an invaluable opportunity for clinicians, allied health professionals, researchers and the MS community to come together to access global innovation and insights, and to network.

And to ensure all who wish to attend are able to do so, delegates have the option of attending the full conference, the one-day community session or an online highlights package.
The keynote themes of the 2023 conference include:

  • Health Behaviour and Modifiable Lifestyle Choices in MS
  • Lab to Clinic for Myelin Repair
  • Lived Experience and Community Involvement in Research
  • Neuroimmunology

This year’s conference boasts a number of high-profile and accomplished international keynote speakers, including;

  • Prof Jeremy Chataway, University College London, UK (Lab to Clinic for Myelin Repair)
  • Professor Wee Yong, University of Calgary, Canada (Neuroimmunology)
  • Prof Robert Motl, University of Illinois, USA (Health Behaviour and Modifiable Lifestyle Choices in MS)

I encourage your involvement at the Progress in MS Research Conference at Pan Pacific Perth, Western Australia. The draft conference program is now available to view.

The program shows the timings across all days and includes information on sessions, topics and speakers.

You can learn more and register here.

Hope to see you there!

Related News

Media Release

Early results show world-first adaptive trial in action for progressive MS

17 September 2026

A potential treatment for progressive multiple sclerosis (MS) will continue in a world-first multi-arm, multi-stage adaptive trial after showing encouraging early signs, with recruitment set to expand across Australia.

MS News

Alpha lipoic acid shows promise in Stage 1 of Octopus trial in progressive MS

17 September 2026

Results from Stage 1 of the Octopus trial find one of the trial treatments, alpha lipoic acid, shows promise in progressive MS and will continue into trial Stage 2.

MS News

Women and MS: one of the disease’s biggest mysteries

9 September 2026

Why does MS affect women more often than men? How does female biology impact MS activity? Discover what recent research is revealing about risk, hormones, immunity and EBV.

Read More

Newsletter subscription

  • This field is for validation purposes and should be left unchanged.

From our CEO